|  Help  |  About  |  Contact Us

Publication : Cholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis.

First Author  Lavine JA Year  2015
Journal  Am J Physiol Endocrinol Metab Volume  309
Issue  10 Pages  E819-28
PubMed ID  26394663 Mgi Jnum  J:229691
Mgi Id  MGI:5753007 Doi  10.1152/ajpendo.00159.2015
Citation  Lavine JA, et al. (2015) Cholecystokinin expression in the beta-cell leads to increased beta-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis. Am J Physiol Endocrinol Metab 309(10):E819-28
abstractText  Cholecystokinin (CCK) is a peptide hormone produced in the gut and brain with beneficial effects on digestion, satiety, and insulin secretion. CCK is also expressed in pancreatic beta-cells, but only in models of obesity and insulin resistance. Whole body deletion of CCK in obese mice leads to reduced beta-cell mass expansion and increased apoptosis. We hypothesized that islet-derived CCK is important in protection from beta-cell apoptosis. To determine the specific role of beta-cell-derived CCK in beta-cell mass dynamics, we generated a transgenic mouse that expresses CCK in the beta-cell in the lean state (MIP-CCK). Although this transgene contains the human growth hormone minigene, we saw no expression of human growth hormone protein in transgenic islets. We examined the ability of MIP-CCK mice to maintain beta-cell mass when subjected to apoptotic stress, with advanced age, and after streptozotocin treatment. Aged MIP-CCK mice have increased beta-cell area. MIP-CCK mice are resistant to streptozotocin-induced diabetes and exhibit reduced beta-cell apoptosis. Directed CCK overexpression in cultured beta-cells also protects from cytokine-induced apoptosis. We have identified an important new paracrine/autocrine effect of CCK in protection of beta-cells from apoptotic stress. Understanding the role of beta-cell CCK adds to the emerging knowledge of classic gut peptides in intraislet signaling. CCK receptor agonists are being investigated as therapeutics for obesity and diabetes. While these agonists clearly have beneficial effects on body weight and insulin sensitivity in peripheral tissues, they may also directly protect beta-cells from apoptosis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

0 Expression